FDA Releases Draft Guidance on Labeling for Human Prescription Drugs Approved Under Accelerated Approval Pathway

Summary

The FDA has released a draft guidance for industry outlining its recommendations for labeling human prescription drugs approved under the accelerated approval pathway, which allows for faster approval of life-saving treatments.